Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 3 days, and 1 more · Every feed →

All 9Congress 0Executive branch 0Insiders 9
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

NAMS · 9 trades

Trades
9
Buys 1 · Sells 8
People
4
Stocks
1
Disclosed value
$9.3M
range midpoints · Congress & executive
Filed late
1
  1. ▼ SELLJohannes Jacob Pieter Kastelein Chief Scientific OfficerNAMS NewAmsterdam Pharma Co N.V.$1.3Mdisclosed Oct 2 · filed 2 days after the trade
  2. ▲ BUYMichael H. Davidson Chief Executive OfficerNAMS NewAmsterdam Pharma Co N.V.$227Kdisclosed Sep 15 · filed 1 day after the trade
  3. ▼ SELLJohn W Smither DirectorNAMS NewAmsterdam Pharma Co N.V.$40.5Kdisclosed Sep 9 · filed 5 days after the trade · late
  4. ▼ SELLJohannes Jacob Pieter Kastelein Chief Scientific OfficerNAMS NewAmsterdam Pharma Co N.V.$3.4Mdisclosed Aug 25 · filed 1 day after the trade
  5. ▼ SELLLouise Frederika Kooij Chief Accounting OfficerNAMS NewAmsterdam Pharma Co N.V.$990Kdisclosed Jul 22 · filed 2 days after the trade
  6. ▼ SELLLouise Frederika Kooij Chief Accounting OfficerNAMS NewAmsterdam Pharma Co N.V.$2.1Mdisclosed Jul 22 · filed 2 days after the trade
  7. ▼ SELLLouise Frederika Kooij Chief Accounting OfficerNAMS NewAmsterdam Pharma Co N.V.$92.4Kdisclosed Jul 22 · filed 2 days after the trade
  8. ▼ SELLLouise Frederika Kooij Chief Accounting OfficerNAMS NewAmsterdam Pharma Co N.V.$9.2Kdisclosed Jun 24 · filed 2 days after the trade
  9. ▼ SELLLouise Frederika Kooij Chief Accounting OfficerNAMS NewAmsterdam Pharma Co N.V.$1.2Mdisclosed Jun 24 · filed 2 days after the trade